Lund-Johansen P - Search Results

1

[Treatment of hypertension in Norway. Indications, therapeutic intensity and economic aspects].

Moan A, Kjeldsen SE, Enger E, Ibsen H, Dahlöf B, Lund-Johansen P. Moan A, et al. Tidsskr Nor Laegeforen. 1992 Jan 10;112(1):69-70. Tidsskr Nor Laegeforen. 1992. PMID: 1553650 Norwegian.

2

[Can treatment of hypertension prevent myocardial infarction? New controlled clinical trials are proposed].

Kjeldsen SE, Syvertsen JO, Lund-Johansen P. Kjeldsen SE, et al. Tidsskr Nor Laegeforen. 1993 Feb 28;113(6):737-40. Tidsskr Nor Laegeforen. 1993. PMID: 8096658 Review. Norwegian.

3

[Status of ongoing controlled clinical trials on hypertension].

Kjeldsen SE, Syvertsen JO, Lund-Johansen P. Kjeldsen SE, et al. Tidsskr Nor Laegeforen. 1996 Jan 10;116(1):61-3. Tidsskr Nor Laegeforen. 1996. PMID: 8553340 Norwegian.

4

[Comparison of preventive effect of "new" and "old" antihypertensive agents].

Kjeldsen SE, Syvertsen JO, Lund-Johansen P, Hildebrandt P, Hansson L. Kjeldsen SE, et al. Tidsskr Nor Laegeforen. 2001 Apr 30;121(11):1374-6. Tidsskr Nor Laegeforen. 2001. PMID: 11419108 Free article. Norwegian.

5

[Limited basis for changing the goals for blood pressure treatment].

Kjeldsen SE, Lund-Johansen P. Kjeldsen SE, et al. Among authors: lund johansen p. Tidsskr Nor Laegeforen. 2016 Feb 9;136(3):209-10. doi: 10.4045/tidsskr.15.1298. eCollection 2016 Feb 9. Tidsskr Nor Laegeforen. 2016. PMID: 26860378 Free article. Norwegian. No abstract available.

6

Comparison of home and office blood pressure in treated hypertensives in the Nordic Diltiazem (NORDIL) Study.

Kjeldsen SE, Hedner T, Syvertsen JO, Lund-Johansen P, Hansson L; NORDIL Group. Nordic Diltiazem. Kjeldsen SE, et al. Blood Press. 2002;11(6):371-6. doi: 10.1080/080370502321095348. Blood Press. 2002. PMID: 12523681

7

Influence of age, sex and blood pressure on the principal endpoints of the Nordic Diltiazem (NORDIL) Study.

Kjeldsen SE, Hedner T, Syvertsen JO, Lund-Johansen P, Hansson L, Lanke J, Lindholm LH, De Faire U, Dahlöf B, Karlberg BE; NORDIL Study Group. Kjeldsen SE, et al. J Hypertens. 2002 Jun;20(6):1231-7. doi: 10.1097/00004872-200206000-00038. J Hypertens. 2002. PMID: 12023696 Clinical Trial.

8

[Treatment of hypertension in the elderly].

Lund-Johansen P. Lund-Johansen P. Tidsskr Nor Laegeforen. 1992 Jun 30;112(17):2179-80. Tidsskr Nor Laegeforen. 1992. PMID: 1523648 Norwegian. No abstract available.

9

Unattended Blood Pressure Measurements in the Systolic Blood Pressure Intervention Trial: Implications for Entry and Achieved Blood Pressure Values Compared With Other Trials.

Kjeldsen SE, Lund-Johansen P, Nilsson PM, Mancia G. Kjeldsen SE, et al. Among authors: lund johansen p. Hypertension. 2016 May;67(5):808-12. doi: 10.1161/HYPERTENSIONAHA.116.07257. Epub 2016 Mar 21. Hypertension. 2016. PMID: 27001295 Review. No abstract available.

10

Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study.

Hansson L, Hedner T, Lund-Johansen P, Kjeldsen SE, Lindholm LH, Syvertsen JO, Lanke J, de Faire U, Dahlöf B, Karlberg BE. Hansson L, et al. Lancet. 2000 Jul 29;356(9227):359-65. doi: 10.1016/s0140-6736(00)02526-5. Lancet. 2000. PMID: 10972367 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

198 results

Search Page